Lixte Biotechnology Holdings, Inc.

UBS Group AG LIXT
Report date
6/30/2026
Quarter
2026 Q2
Filed
8/13/2026
Shares
6,400
Value ($000)
47
Weight
0.0%
2023 Q2 - 2026 Q2 (10 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).